- 4
- 0
- 约2.35万字
- 约 49页
- 2018-12-30 发布于浙江
- 举报
Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The primary endpoint was disease-free survival. Non-inferiority was defi ned as a hazard ratio (HR) of less than 1?25 for no axillary dissection versus axillary dissection. The analysis was by intention to treat. Per protocol, disease and survival information continues to be collected yearly. * Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The prim
您可能关注的文档
- 乳腺癌规范化诊治课件.ppt
- 乳腺癌规范诊疗与进展.ppt
- 绪 言、第一章 健康概述.ppt
- 乳腺癌化放疗精准治疗指南.docx
- 乳腺癌患者术后护理.pptx
- 乳腺癌疾病基础知识.ppt
- 学科专业目录-选专业,填志愿.doc
- 学前教育专业剖析自评报告.doc
- 自身免疫性胰腺炎诊治进展.ppt
- 乳腺癌内科护理 - 副本.ppt
- 码垛机器人国产替代调研.docx
- 2025-2030中国基因测序仪器国产替代进程与市场空间评估.docx
- 2025-2030中国碳化硅功率器件在新能源车中应用渗透与国产替代机遇报告.docx
- 2025-2030中国半导体材料国产替代进程与进口依赖度分析战略研究报告.docx
- 毫米波雷达国产替代研判.docx
- 2025-2030中国电子特气行业进口依赖现状与国产替代机遇.docx
- 2025-2030中国工业软件自主可控路径与国产替代机会报告.docx
- 2025-2030中国MEMS传感器产业链整合与国产替代机遇研究报告.docx
- 中美技术脱钩的上游断供冲击与国产替代的渗透率临界阈值 .docx
- 2025-2030中国第三代半导体氮化镓射频器件国产替代进程与市场机会评估.docx
原创力文档

文档评论(0)